Pfizer acquires Hospira for projected $17bn

06-02-2015

Pfizer acquires Hospira for projected $17bn

Alexstr / Shutterstock.com

US pharmaceutical company Pfizer has agreed to buy drug company Hospira, in an acquisition that will include its biosimilar portfolio.


Pfizer; Hospira; biosimilars; Inflectra; Retacrit

LSIPR